1. Home /
  2. Rumor Mill

Rumor Mill

Possible M&A Surrounds These 3 Stocks

M&A activity has generally slowed.

M&A Appetite in Pharma Has Proved Potent: Chart of the Day

With total deals trending toward hundreds of billions, investors may be eager to bet on who's next to be acquired.

Stay Tuned on Viacom-CBS Deal

A drop in shares doesn't necessarily mean it's time to turn the channel on Viacom, as details of expected merger with CBS will prove 'paramount.'

Who Might the Oil Majors Acquire Next After Chevron's Anadarko Deal?

A rundown of several oil companies that could soon be on the block.

Investors Are Eager to Ride With Lyft IPO on Friday

Lyft's IPO is looking like a party bus, but how long can the sentiment stay strong?

Goldman's Gold Standard in M&A Bolsters Outlook for 2019

Goldman is top of the heap for takeovers.

Takeda Pharmaceutical CEO Talks Big Pharma Trends

One of pharma's biggest CEO's talks M&A action on the exchange.

Celgene Surges as Bristol-Myers Squibb Blockbuster Deal Begins Year With a Bang

Big pharma could be primed for an M&A Boom after Bristol-Myers Squibb's blockbuster deal for Celgene.

Chart of the Day, Part 1: Tilray, AB Deal Pales in Comparison to Cronos

The buy-in from other companies into the space has been far larger.

Huawei and Nissan Arrests Hitting Asian Confidence Hard

Asian markets have been spooked by the fall of these mighty executives.